Levalbuterol HCL Solution

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D221R0116

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
The Defense Logistics Agency (DLA) Troop Support, a federal office, has issued a solicitation for the procurement of Levalbuterol HCL Solution, as indicated by procurement identifier SPE2D221R0116. This notice pertains specifically to the modification and exercise of the third-year option under an existing contract, signaling the agency’s ongoing requirement for this pharmaceutical product. The scope of this procurement centers on the supply of Levalbuterol HCL Solution, a medication commonly used in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The intended outcome is to ensure a reliable and uninterrupted supply of this critical pharmaceutical preparation to support the needs of military personnel and associated beneficiaries. The procurement is classified under NAICS Code 325412, which covers Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, denoting Drugs and Biologicals. These classification codes confirm that the requirement is for the manufacturing and delivery of pharmaceutical-grade products, with strict adherence to industry standards and regulatory requirements. DLA Troop Support, as the contracting entity, is responsible for managing this solicitation. Interested contractors should note that the primary point of contact for this opportunity is Ryan Guarnere, who can be reached via email at [email protected] or by phone at 215-737-2571. The notice remains active as of the posting date, May 8, 2025, and all relevant documentation and attachments can be accessed through the official SAM.gov opportunity listing (Opportunity ID: 8054ebc968c942a0a22e3bf3155c5074). While the solicitation is a modification exercising an option year, contractors should expect to meet all previously established requirements regarding product quality, delivery schedules, and compliance with applicable federal regulations. The procurement type is a standard federal solicitation, and no specific set-aside requirements or special considerations are indicated in the provided information. Contractors with capabilities in pharmaceutical preparation manufacturing, particularly those experienced in producing respiratory medications, are encouraged to review the solicitation details and attachments for comprehensive requirements. This opportunity represents a continuation of a multi-year contract, emphasizing the importance of consistent performance and reliability over the contract lifecycle. For further information, contractors should refer to the official notice and direct any inquiries to the designated contact person.
Documents10